13 Jul 2020
Acute kidney injuries can sometimes trigger the deterioration of small blood vessels and capillaries, leading to chronic kidney disease. But, this process is not completely understood. Now, for the first time, researchers from Daegu Gyeongbuk Institute of Science and Technology, Korea, in collaboration with teams from the University of Pittsburgh and University of Pittsburgh Medical Center, USA, have successfully used ultrasound super-resolution (USR) imaging to observe this process in live mice, revealing the promise of USR as a powerful diagnostic and research tool, and enhancing understanding of the disease.
09 Jul 2020
Researchers from the School of Biomedical Sciences of the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) have recently applied an advanced statistical approach to analyse risk factors that may be causally related to COVID-19 infection. Results suggested that diabetes may be a risk factor leading to increased susceptibility to or severity of COVID-19 infection through changes in ACE2 expression, which is a key receptor for the virus. A substantial proportion of COVID-19 death cases in Hong Kong suffered from diabetes. There is an urgent need to confirm risk factors and the mechanisms in order to protect the susceptible groups and identify effective treatments. The current study results were recently published in the international scientific journal Diabetes Care.
07 Jul 2020
The JUL 2020 regular issue of the Journal of Humanities & Social Sciences Research (JHSSR), Volume 2 (1) JUL. 2020 has been published ahead of time on 30 Jun 2020 and is now live at the Journal’s webpage.
02 Jul 2020
A method that involves infecting liver cells with mosquito-bred parasites could improve the study of malaria in India.
30 Jun 2020
Digital edition of CAREhab – Singapore Rehabilitation Conference 2020 postpones to 17 – 18 July 2020 in light of Singapore General Elections
26 Jun 2020
An International Islamic University Malaysia study highlights the need for strong oral hygiene awareness among school staff caring for disabled children.
19 Jun 2020
The newly established Institute of Health Equity of The Chinese University of Hong Kong (CUHK) has collaborated with the Jockey Club School of Public Health and Primary Care of the Faculty of Medicine at CUHK in a study which investigates the effects of housing affordability on physical and mental health in Hong Kong. The findings show that unaffordable housing worsens the physical and mental health of Hong Kong people, and the relative deprivation of necessities has a mediating role between housing affordability and health. It is the first “health equity” study of its kind in Asia and the results were published in the Journal of Epidemiology and Community Health.
19 Jun 2020
The Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) has recently conducted a global survey to examine the impact of the COVID-19 pandemic on urological care. This is the world’s first survey of its kind and includes a large sample of urology professionals from 6 continents. Results from over 1,000 participants showed that on average 28% of urology outpatient clinics, 30% of outpatient investigations and procedures, and 31% of urological surgeries had a delay of more than 8 weeks. The degree of cut-down of urological services increased with the degree of COVID-19 outbreak.
19 Jun 2020
Have you ever thought about why some people are more vulnerable to catching a virus? And why some get more severe infection than others? Gut microbiota, which is a fine balance between good and bad bacteria, regulates our immune system. Imbalance in gut microbiota (dysbiosis) will make us susceptible to infections.
18 Jun 2020
* CAREhab 2020 in conjunction with 6th Singapore Rehabilitation Conference to take place virtually via tech-enabled CAREhab GO platform live on 10-11 July * Delegates to have full access to digital library of video content and exhibition showcase in their own time from 10 July 2020 to February 2021, meeting convenient learning needs
17 Jun 2020
The journal provides a fast and convenient route to the most recently published articles in your subject areas. It's important to stay alert!
12 Jun 2020
Researchers at the University of Tsukuba and RIKEN in Japan spark a hibernation-like state in mice—a species that does not naturally hibernate
04 Jun 2020
Researchers from University of Tsukuba and the University of Tokyo identify neurons responsible for memory consolidation during REM sleep
03 Jun 2020
A highly accurate machine learning tool could help doctors tailor individualized treatments for people with glioma brain tumours.
29 May 2020
An international collaborative team from PROS Ehime University and CellFee Science, Japan; the Walter and Eliza Hall Institute, Australia; Pasteur Institute, France; and Foundation for Innovative New Diagnostics, Switzerland developed a new diagnostic blood test which detects recent exposure to ‘vivax’ malaria. The new test can also identify people who may harbor dormant liver-stage malaria parasites, which can cause illness. This new diagnostic approach has the potential to enhance malaria surveillance and accelerate elimination.
28 May 2020
A team of scientists and researchers from A*STAR’s Singapore Immunology Network and Jinan University, Guangzhou, have deciphered human embryonic immune cell development and discovered how the earliest macrophages in humans, a type of white blood cell of the immune system, stems from a distinct embryonic source and not the bone marrow.
27 May 2020
A team of young researchers led by Professor JIANG Yangzi, Research Assistant Professor at the Institute for Tissue Engineering and Regenerative Medicine (iTERM) and the School of Biomedical Sciences (SBS) at The Chinese University of Hong Kong (CUHK), has recently been granted funding from the National Key Research and Development (R&D) Programme. It is the first team in Hong Kong to receive national-level, cross-border research funding under the “Young Scientist Scheme” of the Programme. The team has been awarded a research grant of RMB 5.45 million (approximately HKD 6 million) for basic and preclinical research on the pathogenesis of osteoarthritis.
26 May 2020
Scratching the head or rubbing the hands repeatedly is common, unconscious behaviour when people are facing stress. Neuroscientists from the School of Biomedical Sciences and the Gerald Choa Neuroscience Centre of the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) have discovered a mammalian brain circuitry underlying our ability to generate adaptive responses when facing stress with strong negative emotions. The result of the study was recently published in the renowned international scientific journal Nature Communications.
25 May 2020
Wastewater could be used as a surveillance tool to monitor the invasion, spread and eradication of COVID-19 in communities.
21 May 2020
A group of Hokkaido University researchers has developed a paper-based device that can easily and cheaply measure lithium ion concentration in blood, which could greatly help bipolar disorder patients.
19 May 2020
A recent study conducted by the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) discovered a novel genetic biomarker which can predict the survival of head and neck cancer patients. There are over 0.7 million new head and neck squamous cell carcinoma (HNSCC) cases globally each year. However, currently there is no clinical implementation of any genetic biomarker to predict outcomes for these patients after standard treatment. A study led by Professor Vivian Wai Yan LUI, an expert in genomic medicine and Associate Professor of the School of Biomedical Sciences at CU Medicine, and her research team, has identified that mitogen activated protein kinase (MAPK) pathway mutations found in almost 20% of HNSCC patients can predict favourable clinical outcomes with standard therapy. Their survival also doubled when compared with other patients. The finding has just been published in the journal Life Science Alliance.
18 May 2020
Professor Tony MOK from the Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine) and Professor LU You from West China School of Medicine at The Sichuan University co-led the world’s first-in-human Phase I clinical trial investigating the safety and feasibility of CRISPR gene-edit therapy as a treatment option for patients with late stage lung cancer. Research team recruited 22 advanced Non-small-cell lung carcinoma (NSCLC) patients and isolate the T cell (a form of white blood cell) from peripheral blood. After gene-editing by CRISPR, the T cells that were reinfused back to patient may have the ability to attack cancer cell. Objective of the study is to demonstrate safety and feasibility. Results demonstrated CRISPR technology is safe and feasible as patients showed no severe adverse events and the frequency of off-target events was only 0.05%. This opens a new chapter in the history of lung cancer immunotherapy. The findings were recently published on-line in the international medical journal Nature Medicine.
15 May 2020
As a first-in-the-world "rapid smart test kit", the cPass™ which can measure neutralising antibodies in an hour will be a huge boost to current COVID-19 investigations, from contact tracing, sero-prevalence survey, and assessment of herd immunity, longevity of protective immunity and efficacy of different vaccine candidates.
13 May 2020
Diagnosis of Alzheimer's disease, the most common type of dementia, is not easy for its overlapping signs with normal ageing. A collaborative research by City University of Hong Kong (CityU) and Johns Hopkins University has developed a new non-invasive molecular imaging approach based on Magnetic Resonance Imaging (MRI) to dynamically measure glucose level changes in the brain lymphatic system. Their discovery may help in identifying Alzheimer's disease at early stages so that treatments can start as soon as possible.
13 May 2020
Insights into a flipping crystal could further research into the development of autonomous robots.
11 May 2020
A research team led by Hong Kong Baptist University (HKBU) has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein produced by EBV, leading to the shrinkage of tumours caused by the virus. It is the first known agent to successfully target the virus and disturb its latency in tumour cells in this way.
08 May 2020
When the master regulator of protein production malfunctions, it may contribute to the development of neuronal diseases such as Alzheimer's and Huntington's.
30 Apr 2020
The UK today confirmed that it will be the largest supporter of the international alliance to vaccinate children against deadly diseases, saving millions of lives.
28 Apr 2020
A research team led by Hong Kong Baptist University (HKBU) has launched an online cognitive behavioural therapy (CBT) programme. Introduced in April 2020 for Hong Kong people with mild to moderate depressive symptoms, the programme provides them with easy access to counselling services and reduces the stigma associated with depression. The team will recruit 400 participants aged between 18 and 70 with depressive symptoms and provide training next year to around 200 local mental health professionals on how to operate this online CBT programme, with the aim of serving more people in the long run.
16 Apr 2020
A small mitochondrial protein is necessary for energy production and its malfunction could be behind a range of degenerative diseases, according to study by Duke-NUS Medical School and their collaborators.
01 Oct 2020
The 6th annual RNA Biology Symposium jointly organized by the RNA Biology Centre of CSI Singapore (NUS), Skin Research Institute of Singapore (A*STAR), Duke-NUS Medical School, School of Biological Sciences (NTU) and Singapore-MIT Alliance for Research and Technology (SMART)
26 Jun 2020
Flattening the Curve with Digital Health: Episode 7 - Australia
18 Jun 2020
Flattening the Curve with Digital Health: Episode 6 - Thailand
10 Jun 2020
Flattening the Curve with Digital Health: Episode 5 - Japan
23 Sep 2020
Adapting to COVID 19, and driving a pivotal change in drug trials, market penetration, pricing and regulatory compliance
01 Sep 2020
Celebrating and learning from COVID 19 success stories to shape new frontiers in patient experience, healthtech and innovation.
22 Jul 2020
Due to the COVID-19 pandemic affecting international travel, this year's event will be a unique blend of online and live gatherings — BIO Asia–Taiwan 2020 Online + Live, to be held July 22-26 in Taipei, Taiwan.
07 Sep 2020
This conference has been shifted to 7 - 8 September 2020
21 Aug 2020
Singapore's long-running Pharmaceutical Manufacturing Industry learning and networking event, featuring a stellar profile of C-suite experts and firms.
03 Nov 2020
Postponement of Biopharma Development & Production (BDP) China 2020 to 3-4 November 2020.
17 Jul 2020
Asia’s annual premier healthcare platform CAREhab 2020 and conference element 6th Singapore Rehabilitation Conference, will now be held online on the 17 – 18 July 2020.
07 Jul 2020
IMAPAC is bringing to you 3 focus areas: Bio-Manufacturing, Bio-Analytics, and Cell Therapy Bioprocessing as part of Asia's biggest, most focussed annual bioprocessing virtual conference!
09 Dec 2019
The ASEAN Emerging Researchers Conference is a flagship programme of the ASEAN Young Scientists Network; the official platform for young researchers in the region.
26 Nov 2019
Vaccine World Asia 2019 will bring together leading experts to discuss the latest technological advancements and spearhead scientific innovation in the development and manufacture of vaccines for key diseases such as Dengue, Chikungunya, Malaria, Tuberculosis etc.
02 Oct 2019
Launching on 2nd October 2019 in Singapore
13 Jan 2020
Duxes is pleased to announce the launch of the Smart Wearable Device Asia Pacific Summit 2020 (SWAP), that will take place in Shenzhen, China. January 13-14. This upcoming event aims to meet the latest demands of companies in the smart wearable device market, shedding light on current hot topics, industry concerns and the latest innovations.
07 Oct 2019
Tracks include: Sustainability & Growth; Patient Experience; Unlocking the Value of AI; Value-based Care.
Duke-NUS Medical School
Dr Danielle Anderson is the Scientific Director of the Duke-NUS Medical School ABSL3 laboratory.
Manabu Tokeshi is a Professor at the Division of Applied Chemistry at Hokkaido University.
A professor at the Bone Regenerative Engineering Laboratory, Regenerative and Biomedical Engineering Division, Graduate School of Biomedical Engineering, Tohoku University, Japan
Institute for Integrated Cell-Material Sciences (iCeMS) at Kyoto University
My research background covers multidisciplinary fields such as Pharmaceutics, Cancer Nanomedicine, Bioengineering and Organ-on-a-chip platforms. My current research focuses on the development of dynamic biological barriers on a chip such as blinking human cornea on a chip.
Hidemitsu Kitamura is an associate professor at the Section of Disease Control, the Institute for Genetic Medicine, Hokkaido University, Japan.
The Chinese University of Hong Kong (CUHK)
Li Zhang is an Associate Professor in the Department of Mechanical and Automation Engineering (MAE) and an associate faculty member in Chow Yuk Ho Technology Centre for Innovative Medicine (TIM) and T Stone Robotics Institute (CURI) at The Chinese University of Hong Kong (CUHK). He is also the co-director of CAS SIAT-CUHK Joint Laboratory of Robotics and Intelligent Systems.
Professor Samuel Wong is a clinician with training in both Family Medicine and Public Health. He received his Doctor of Medicine degree from the University of Toronto and completed his Family Medicine residency training in Canada. He completed the Master of Public Health at the Johns Hopkins University, USA and the Doctor of Medicine (MD) research degree at The Chinese University of Hong Kong. He is the Head of the Division of Family Medicine and Primary Healthcare and the Deputy Director of the School of Public Health and Primary Care since 2019. He has been the Co-Director of the Master of Public Health Programme since 2018 and is the Director of Thomas Jing Centre for Mindfulness Research and Training. He has also been appointed as the Associate Dean (Education) of the Faculty of Medicine since July 2019. Professor Wong’s research interests include evaluating and developing mindfulness- based and mental health interventions in primary care; evaluating primary care services and developing primary care service models as well as multimorbidity.
Universiti Teknologi MARA (UiTM)
Kartini Ilias is a senior lecturer and clinical psychologist in Faculty of Health Sciences, Universiti Teknologi MARA, Puncak Alam, Selangor.
Korea Advanced Institute of Science and Technology (KAIST)
Professor in Electrical Engineering at Korea Advanced Institute of Science and Technology (KAIST).
Prof. Dr. Francisco J. Barrantes is the Head of the Laboratory of Molecular Neurobiology, BIOMED UCA-CONICET, Buenos Aires, Argentina.
DR. Rey Tiquia is a Chinese technoscience philosopher at the School of Historical and Philosophical Studies at the University of Melbourne. Technoscience’ is a knowledge system that is closely linked to society and nature and vice-versa. This philosophy sees no dichotomy between science and technology. Each is an extension and embodiment of the other. Rey does research in Qualitative Social Research, Sociological Translation and Medical Anthropology. His current project is 'Restoring the Chinese Calendar 'Lifa' and the Cosmic Breath 'Qi' to the Real World.' As an independent Chinese technoscience researcher, he studies the metaphysical value of the Cosmic Breath 'Qi' and the Transnational Elemental Stems and Zodiacal Branches Calendrical Clock (Northern and Southern Hemispheres)to interrupt the decline of traditional Chinese Medicine and other Chinese technoscientific practices and their respective prognosticative power as mobile bodies of local knowledge while ensuring their continued innovation and regeneration.
Yoshihiko Kadoya is a Distinguished Researcher of Hiroshima University, the Director of Hiroshima Institute of Health Economics Research (HiHER) and a Professor of Economics at Hiroshima University.
The Chinese University of Hong Kong (CUHK)
Professor, School of Life Sciences, The Chinese University of Hong Kong
Daegu Gyeongbuk Institute of Science and Technology (DGIST)
Prof. SU-IL IN has been working at DGIST (Daegu Gyeongbuk Institute of Science & Technology) since 2012. He served as Dean of International and External Affairs 2016 ~ 2017. He received his Ph.D. in Chemistry from University of Cambridge in 2008. Subsequently he was a postdoctoral researcher at Technical University of Denmark by 2010. Then he joined the Pennsylvania State University as a postdoctoral researcher in the Department of Chemistry before joining DGIST. Professor In’s current researches include synthesis and analysis of functional nano (bio)-materials for environmentally friendly renewable energy such as photovoltaic, heterogeneous catalysis and biocatalysts. (https://insuil.dgist.ac.kr/)
Toru Kondo is Professor of the Division of Stem Cell Biology at the Institute for Genetic Medicine, Hokkaido University.
Professor and Head of Microbiology and Immunology Department, Faculty of Medicine, Lincoln University College (LUC) Malaysia.